Rise of the new dominant in targeting the undruggables

November 01, 2011 | Analyst Insight

Following our very recent updates on siRNA delivery company, Calando Pharmaceuticals (see the October 4, 2011 LTRJ), its parent company Arrowhead Research announced a significant takeover in the field. With this...